BUZZ—U.S. Stock Market Update—SpaceX, Humana, Crescent Energy
路透社2026/10/09 13:12Query string for tracking individual stock trends: STXBZ "Today's Outlook" newsletter: https://refini.tv/3LI4BU7 "Morning News Briefing": https://refini.tv/3dKUyB8 Reuters, October 9 – On Friday, U.S. stock indices are expected to open higher, boosted by falling oil prices as concerns over Middle East supply ease, although telecom stocks remain under pressure amid worries of increased industry-wide competition following SpaceX's spectrum acquisition. ** T-Mobile US Inc TMUS.O: In Discussion – European telecom stocks fell after SpaceX's spectrum deal nL6N45V0EH ** SpaceX SPCX.O: In Focus – Shares rose after reaching an agreement to acquire a nationwide low-band spectrum portfolio nL4N45V0KP ** Humana Inc HUM.N: In Focus – Shares rose on the back of an upgraded rating for its “Federal Medicare Advantage Plan” [nL4N45V0LU ** Definium Therapeutics Inc DFTX.O: Market Watch – Stock rose after JPMorgan rated its LSD-based therapies as “Overweight” nL4N45V0NH ** UnitedHealth Group Inc UNH.N: Market Update – TD Cowen lowered its price target ahead of UnitedHealth’s Q3 financials nL4N45V0OU ** Newmont Corporation NEM.N: ** Gold Fields Ltd GFI.N: ** Harmony Gold Mining Company HMY.N: ** AngloGold Ashanti AU.N: Market Update – Gold miner stocks rose modestly as gold prices moved up on weaker dollar nL4N45V0PG ** Delta Air Lines DAL.N: Market Flash – Shares dropped after sharply cutting its full-year profit guidance nL4N45V0RA ** Apple AAPL.O: In Focus – Shares fell on reports of iPhone production cuts nL4N45V0SB ** Crescent Energy CRGY.N: Market Update – Shares dropped after it raised $1 billion to acquire Devon Energy nL6N45V0J4 ** Medtronic MDT.N: ** Tandem Diabetes Care Inc TNDM.O: ** PROCEPT BioRobotics Corp PRCT.O: ** Insulet Corporation PODD.O: Market Update – Leerink says industry-wide growth concerns for med-tech may outweigh Q3 results nL4N45V0YE (For the convenience of non-English speakers, Reuters automates translation of its reports into several languages. Because automated translations may contain errors or fail to capture the intended context, Reuters does not guarantee the accuracy of these texts and provides them solely for reader convenience. Reuters assumes no liability for any damages or losses resulting from the use of automated translation features.)
Reuters, October 9 - On Friday, U.S. stock indexes are expected to open higher, boosted by falling oil prices as concerns over Middle East supply ease, but telecom stocks remain under pressure as SpaceX's spectrum acquisition sparks industry-wide competition worries. .N
** T-Mobile US Inc TMUS.O:
Trending - European telecom stocks fall after SpaceX spectrum deal nL6N45V0EH
** Space Exploration Technologies Corp SPCX.O:
Highlight - Shares up after reaching an agreement to acquire a nationwide low-frequency spectrum portfolio nL4N45V0KP
** Humana Inc HUM.N:
Highlight - Shares rise as the "Medicare Advantage Plan" rating improves [nL4N45V0LU
** Definium Therapeutics Inc DFTX.O:
Market Trending - Shares rise after JPMorgan gives an "overweight" rating to its LSD-based therapy nL4N45V0NH
** UnitedHealth Group Inc UNH.N:
Market Alert - TD Cowen lowers its target price ahead of UnitedHealth's Q3 results nL4N45V0OU
** Newmont Corporation NEM.N:
** Gold Fields Limited GFI.N:
** Harmony Gold Mining Company Limited HMY.N:
** AngloGold Ashanti Limited AU.N:
Market Alert — Gold prices edge higher as the dollar weakens, lifting gold miner stocks nL4N45V0PG
** Delta Air Lines Inc DAL.N:
Market Flash — Shares fall after sharply lowering annual earnings forecast nL4N45V0RA
** Apple AAPL.O:
Highlight - Shares fall on reports of iPhone production cuts nL4N45V0SB
** Crescent Energy Company CRGY.N:
Market Alert - Shares fall after raising $1 billion to acquire Devon Energy nL6N45V0J4
** Medtronic plc MDT.N:
** Tandem Diabetes Care Inc TNDM.O:
** PROCEPT BioRobotics Corp PRCT.O:
** Insulet Corporation PODD.O:
Market Alert — Leerink says concerns over growth in the MedTech sector may overshadow Q3 earnings nL4N45V0YE
(To assist non-native English speakers, Reuters has automated the translation of its reports into several other languages. Since automated translation may contain errors or lack necessary context, Reuters does not guarantee the accuracy of automated translation texts and provides them solely for readers' convenience. Reuters accepts no liability for any harm or loss arising from the use of automated translation features.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
University of Michigan October Consumer Sentiment Index falls to a five-month low, with the Current Economic Conditions Indicator hitting a historic low
The University of Michigan’s Consumer Sentiment Index for October dropped to 46.3, below the market expectation of 47.6. The component reflecting current economic conditions decreased to 44.7, setting a new historical low, while the expectations component edged up to 47.3, marking its first rebound since July. Consumers’ one-year inflation expectations rose to 4.7%, and five-to-ten-year inflation expectations increased to 3.5%. According to the survey director, consumers from different political parties agree that the economic outlook has weakened compared to the beginning of the year.
WTI holds steady as traders weigh US-Iran tensions and supply risks
Japan: Bond outflows reshape global yields - Commerzbank
BUZZ - JPMorgan gives “overweight” rating to LSD-based therapies, Definium stock rises
Latest Updates, October 9th - ** Definium Therapeutics (DFTX.O) shares rose 7.4% to $36.7 ** If the rally holds, the stock is set for its biggest single-day gain since June ** JPMorgan initiated coverage of the stock with an "Overweight" rating and a target price of $84 ** The bank stated that Definium’s lead candidate drug, DT120 ODT, has the potential to transform the treatment landscape for neuropsychiatric disorders ** Based on current data, the institution considers DT120 ODT (an LSD oral formulation for the treatment of major depressive disorder and generalized anxiety disorder) to be a "de-risked asset" ** The new target price implies a 145.7% upside from the latest closing price ** "While changes in the macro environment may present potential investment risks to the sector, we believe the positives for Definium outweigh the negatives," the bank stated ** A period of "frequent landmark events" is expected ahead, including plans to submit a new drug application to the FDA in the first half of 2027 ** The bank projects that total sales of DT120 orally disintegrating tablets (ODT) will approach $5 billion by 2035 ** Including intraday volatility, the stock has more than doubled in value year-to-date (For the convenience of non-English speakers, Reuters has automated this report’s translation into several other languages. Due to possible errors in automated translation or lack of full context, Reuters does not guarantee the accuracy of the automated translation and provides it solely as a convenience to readers. Reuters accepts no liability for any damage or loss arising from the use of automated translation.)
Crypto prices
More
